(Q43042467)

12 November 2017

title

Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India (English)

1 reference

12 November 2017

1 reference

7

Priya Abraham

1 reference

12 November 2017

3

Gopalan Sridharan

1 reference

12 November 2017

1

Sukanya Raghuraman

1 reference

12 November 2017

5

George Chandy

1 reference

12 November 2017

R V Shaji

2

1 reference

12 November 2017

Sujatha Radhakrishnan

series ordinal

4

1 reference

12 November 2017

B S Ramakrishna

series ordinal

6

1 reference

12 November 2017

language of work or name

1 reference

1 January 2003

1 reference

Journal of Clinical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

26

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

61-69

1 reference

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Hepatitis C virus in dialysis units: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

HCV infection in hemodialyzed patients: incidence and correlation with dialytic age

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Hepatitis C antibody and chronic liver disease in haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Typing of hepatitis C virus genomes by restriction fragment length polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Genotype determination of hepatitis C virus from northern India: identification of a new subtype

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Severity of liver disease with different hepatitis C viral clones

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Importance of sexual transmission of hepatitis C virus in seropositive pregnant women: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Vertical transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Diversity of genotypes of hepatitis C virus in southern India

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900025-2

7 January 2021

10.1016/S1386-6532(02)00025-2

Identifiers

DOI

1 reference

12 November 2017

1 reference